Executives tend to downplay any negative effects of AI and automation on their employees -- but what they say in private is different.

Costs for CAR T-cell therapies will be far higher than many have imagined, reaching $1 million or more per patient, according to leading cancer experts. The next CAR T-cell drug could be approved as soon as November.

Tom Marino, withdrew from consideration following reports that he pushed legislation making it harder for the government to combat the opioid crisis.

The GOP tax plan might be creating uncertainty in your mind or your clients' -- this analysis offers some timely tips for dealing with that.